v3.26.1
SCHEDULE OF SEGMENT REPORTING (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
Revenues $ 1,035 $ 530
Cost of revenues (1,274) [1] (5,774) [2]
Gross profit (loss) (239) (5,244)
Cost of development services and research and development expenses (9,002) [1] (10,311) [2]
Operating expenses (10,095) [1] (35,088) [2]
Impairment of investment (18,338) [3] (699)
Share in net income of associated companies (8) (734)
Profit from deconsolidation 4,480 (5,343)
Other income, net 606 4
Depreciation and amortization (2,086) (1,560)
Loss from extinguishment in connection with convertible loan (5,422) (283)
Credit loss on convertible loan receivable (2,688)
Financial Expenses, net (4,508) (2,499)
Finance fees related to convertible loans to equity (4,304)  
Income (loss) before income taxes (48,916) (64,445)
Octomera [Member]    
Segment Reporting Information [Line Items]    
Revenues 533 68
Cost of revenues (1,351) [1] (9,505) [2]
Gross profit (loss) (818) (9,437)
Cost of development services and research and development expenses (4,530) [1] (9,211) [2]
Operating expenses (3,557) [1] (37,878) [2]
Impairment of investment (6,509) [3]
Share in net income of associated companies
Profit from deconsolidation
Other income, net 1,022 1
Depreciation and amortization (1,558) (1,765)
Loss from extinguishment in connection with convertible loan
Credit loss on convertible loan receivable
Financial Expenses, net (4,682) (573)
Finance fees related to convertible loans to equity  
Income (loss) before income taxes (20,632) (58,863)
Therapies [Member]    
Segment Reporting Information [Line Items]    
Revenues 525 515
Cost of revenues (633) [1] (690) [2]
Gross profit (loss) (108) (175)
Cost of development services and research and development expenses (5,169) [1] (5,811) [2]
Operating expenses (10,716) [1] (7,102) [2]
Impairment of investment (11,829) [3] (699)
Share in net income of associated companies (8) (74)
Profit from deconsolidation
Other income, net (416) 3
Depreciation and amortization (771) (782)
Loss from extinguishment in connection with convertible loan (5,422) (283)
Credit loss on convertible loan receivable (2,688)
Financial Expenses, net 49 (2,004)
Finance fees related to convertible loans to equity (4,304)  
Income (loss) before income taxes (38,694) (19,615)
Eliminations [Member]    
Segment Reporting Information [Line Items]    
Revenues (23) (53)
Cost of revenues 710 [1] 4,421 [2]
Gross profit (loss) 687 4,368
Cost of development services and research and development expenses 697 [1] 4,711 [2]
Operating expenses 4,178 [1] 9,892 [2]
Impairment of investment [3]
Share in net income of associated companies (660)
Profit from deconsolidation 4,480 (5,343)
Other income, net
Depreciation and amortization 243 987
Loss from extinguishment in connection with convertible loan
Credit loss on convertible loan receivable
Financial Expenses, net 125 78
Finance fees related to convertible loans to equity  
Income (loss) before income taxes $ 10,410 $ 14,033
[1] Excluding Depreciation, amortization and impairment expenses
[2] Excluding Depreciation, amortization and impairment expenses
[3] Relates to impairment expenses on certain property, plant and equipment.